Regentis Biomaterials Ltd. (AMEX: RGNT) last traded at $2.10, up 1.94% on the session. The quote above updates while this page is open; the figures below are drawn from Regentis Biomaterials Ltd.’s own filings and are restated only when a new one is published.
Regentis Biomaterials Ltd. (RGNT) company overview
Regentis Biomaterials Ltd. trades on AMEX under the ticker RGNT. Its market capitalisation is $10.88 million.
RGNT valuation
Valuation measures for Regentis Biomaterials Ltd., derived from the latest quote and its most recent SEC filing.
Market cap
$10.88M
Enterprise value
$6.37M
Price / book
2.29
Beta
9.09
RGNT financials
Trailing-twelve-month figures tagged in Regentis Biomaterials Ltd.'s XBRL filings with the SEC.
Net income (TTM)
-$13.65M
Return on equity
-287.69%
Cash
$7.38M
RGNT trading statistics
Range and volume for RGNT over the past 52 weeks.
52-week high
$15.50
52-week low
$1.23
Volume
37.1K
Average volume
5.32M
Previous close
$2.06
Regentis Biomaterials Ltd. (RGNT) FAQs
What is the RGNT stock price today?
Regentis Biomaterials Ltd. (RGNT) last traded at $2.10, up 1.94% on the session. FurlPay quotes RGNT from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is RGNT listed on?
Regentis Biomaterials Ltd. is listed on AMEX under the ticker symbol RGNT.
What is Regentis Biomaterials Ltd.'s market cap?
Regentis Biomaterials Ltd. has a market capitalisation of $10.88 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is RGNT's 52-week range?
Over the past 52 weeks RGNT has traded between $1.23 and $15.50.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001912966), period ending 2025-12-31.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.